drugset / Trial / NCT07076641

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

NCT07076641

Phase 3 Not yet recruiting 76 enrolled Ramsay Santé Euraxi Pharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the superiority of IV lidocaine combined with morphine spinal anesthesia versus placebo combined with morphine spinal anesthesia, in reducing postoperative morphine consumption at 48 hours, in patients undergoing major digestive or abdominal surgery by laparotomy.

Timeline

Start
2026-07
Primary completion
2027-07-30
Completion
2027-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Background Morphine Other / unclassified Intrathecal